… a phenomenon called functional antagonism [17]. With this in mind, we have hypothesized
that a bioassay based on a strong functional antagonism between MCh and salbutamol might …

… We evaluated agreement between the Finney bioassay and … the Diskus in lung delivery of
salbutamol in asthma patients. … clinical bioassay based upon a strong functional antagonism …

… salbutamol is needed for the same degree of antagonism ie … to MeCh inhaled 3 different
formulations of salbutamol; Aerolin … of asthma or atopy, of viral infection within the previous two …

… of methods based on effectiveness, a bioassay has been … did not antagonize salbutamol,
so no functional consequence … of muscarinic antagonists on histamine inhaled in asthmatics is …

… the inhaler to release one dose (90 μg) of albuterol into the … available to the patient from the
devices, we chose to use the … presence of endogenous functional antagonists acting at the β …

… between inhaler activation and inhalation led to a greater likelihood of uncontrolled asthma
symptoms and a higher rate of … of bronchodilators delivered by virtually any inhalation device …

… large bronchodilator doses in patients with severe acute asthma … response between spacers
and other inhalation devices, … by either the salbutamol dose or inhalation devices, possibly …

… or asthma that studied the in-company evolution of inhaler … the bronchodilator efficacy of
indacaterol delivered via the … powder inhaler with two blister strips from which inhalation powder …

… compare the efficacy of inhaled bronchodilator treatment with a … visit rate after admission
while we assessed duration of acute … that compared salbutamol via metered dose inhaler via …

… trial clinical effects of salbutamol inhaled through pMDI with a … inhaled bronchodilators and
corticosteroids will remain the cornerstone of asthma therapy, development of inhaler devices …